Literature DB >> 224698

Comparative epidemiology of two rotavirus serotypes and other viral agents associated with pediatric gastroenteritis.

C D Brandt, H W Kim, R H Yolken, A Z Kapikian, J O Arrobio, W J Rodriguez, R G Wyatt, R M Chanock, R H Parrott.   

Abstract

Human rotavirus (HRV) type 1 or 2, adenovirus, or non-cultivatable 27 nm virus-like particles were demonstrated by electron microscopy and/or rotavirus ELISA in fecal samples from 45.5% of 604 gastroenteritis inpatients, 25.0% of 200 gastroenteritis outpatients and 6.0% of 812 control subjects, all sampled at Children's Hospital National Medical Center. Washington, DC. Rotaviruses were the most common pathogens detected as 39% and 22% of gastroenteritis inpatients and outpatients, respectively, shed HRV. About three-fourths of the rotaviruses were type 2, which was prevalent during five successive epidemic years from January, 1974, through June, 1978. HRV type 1 was detected in the last four successive epidemic years and represented nearly half of the HRV infections observed among gastroenteritis inpatients during the year 1977--1978. Both rotavirus serotypes were detected most often in the month of January, when 71% of 123 gastroenteritis inpatients and 62% of 34 gastroenteritis outpatients shed one of these viruses. Uncultivatable adenoviruses were detected significantly more frequently in stools from patients with gastroenteritis (3.9%) than from control subjects (0.6%), suggesting that these viruses played a role in acute enteric disease. The frequency of detection of 27 nm particles was not significantly different in gastroenteritis and control patients. Numerically, HRV infection was detected most often in gastroenteritis inpatients who were 10 through 12 months of age. The group of gastroenteritis inpatients with the highest percentage of HRV infection was 13 through 15 months of age. The excess of type 2 HRV infection relative to type 1 infection was especially large in those aged 7 through 24 months. Lower socioeconomic status or greater crowding appeared to be associated with the occurrence of rotavirus infection earlier in life and earlier in the epidemic year.

Entities:  

Mesh:

Year:  1979        PMID: 224698     DOI: 10.1093/oxfordjournals.aje.a112809

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  49 in total

1.  DNA hybridization for diagnosis of enteric adenovirus infection from directly spotted human fecal specimens.

Authors:  G Hammond; C Hannan; T Yeh; K Fischer; G Mauthe; S E Straus
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

2.  Genetic organization, size, and complete sequence of early region 3 genes of human adenovirus type 41.

Authors:  H Y Yeh; N Pieniazek; D Pieniazek; R B Luftig
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  Adenovirus types 40 and 41 and rotaviruses associated with diarrhea in children from Guatemala.

Authors:  J R Cruz; P Cáceres; F Cano; J Flores; A Bartlett; B Torún
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

4.  Asymptomatic rotavirus infections in day care centers.

Authors:  B L Barrón-Romero; J Barreda-González; R Doval-Ugalde; J Zermeño-Eguia Liz; M Huerta-Peña
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

5.  Restriction enzyme analysis of faecal adenoviruses in Newcastle upon Tyne.

Authors:  M M Willcocks; M J Carter; F R Laidler; C R Madeley
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

6.  Specific properties of two enteric adenovirus 41 clones mapped within early region 1A.

Authors:  A K Allard; G Wadell; K M Evander; G K Lindman
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

7.  Cloning and physical mapping of enteric adenoviruses (candidate types 40 and 41).

Authors:  H E Takiff; W Reinhold; C F Garon; S E Straus
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

Review 8.  Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial.

Authors:  M Van der Wielen; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-20       Impact factor: 3.267

9.  Molecular epidemiology of human rotaviruses in Melbourne, Australia, from 1973 to 1979, as determined by electrophoresis of genome ribonucleic acid.

Authors:  S M Rodger; R F Bishop; C Birch; B McLean; I H Holmes
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

10.  Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations.

Authors:  Sarah M McDonald; Jelle Matthijnssens; John K McAllen; Erin Hine; Larry Overton; Shiliang Wang; Philippe Lemey; Mark Zeller; Marc Van Ranst; David J Spiro; John T Patton
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.